Proposed combination treatment strategy to tackle p53‐mutant esophageal squamous cell carcinoma (ESCC) tumors with a WEE1 inhibitor
Proposed combination treatment strategy to tackle p53‐mutant esophageal squamous cell carcinoma (ESCC) tumors with a WEE1 inhibitor. Cotreatment with trifluridine (FTD) and MK1775 inhibited ataxia telangiectasia and Rad3‐related protein (ATR)‐checkpoint kinase 1 (CHK1)‐WEE1, a compensation DNA damage response pathway in p53‐mutant ESCC cells, resulting in cytotoxicity via synthetic lethality.
Publication
Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma (2023) Trang H. Nguyen Vu, et al. Cancer Sci. 2023 Dec;114(12):22452. Figure: F5.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | G2 | G2 | ncbigene_synonym | WARS1 | 7453 |
| Homo sapiens | Primates | RPA2 | RPA2 | ncbigene_symbol | RPA2 | 6118 |
| Homo sapiens | Primates | RPA2 | RPA2 | ncbigene_synonym | POLR1B | 84172 |
| Homo sapiens | Primates | (DDR) | DDR | ncbigene_synonym | DDR1 | 780 |
| Homo sapiens | Primates | (DDR) | DDR | famplex_relations | DDR2 | 4921 |
| Homo sapiens | Primates | WEE1 | WEE1 | ncbigene_symbol | WEE1 | 7465 |
| Homo sapiens | Primates | ATM | ATM | ncbigene_symbol | ATM | 472 |
| Homo sapiens | Primates | CHK2 | CHK2 | ncbigene_synonym | CHEK2 | 11200 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_symbol | ATR | 545 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_synonym | ANTXR1 | 84168 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_synonym | MMAB | 326625 |
| Homo sapiens | Primates | ATR | ATR | ncbigene_synonym | SERPINA2 | 390502 |
| Homo sapiens | Primates | CHK1 | CHK1 | ncbigene_synonym | CHEK1 | 1111 |
| Homo sapiens | Primates | CDK1 | CDK1 | ncbigene_symbol | CDK1 | 983 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|